Subscribe free

HPB & Spleen ·

KRAS and RYR2 mutations significantly predict unresectable recurrence

The study identified several key prognostic factors impacting unresectable recurrence-free survival (urfs) in colorectal liver-only metastasis patients. Significant predictors included KRAS G12D mutation positivity (HR: 7.69), RYR2 mutation positivity (HR: 4.03), KRAS G12S mutation positivity (HR: 3.96), CA19-9 > 37 U/ml prior to hepatectomy (HR: 3.62), and primary tumor PN2 stage (HR: 3.22). These findings underscore the importance of specific mutations in shaping patient outcomes.

Journal Article by Chen K, Okamura Y (…) Yamaguchi K et 13 al. in Surg Today

© 2024. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd.

read the whole article in Surg Today

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

All papers in HPB & Spleen →